Armin Friedli
Psychiatry · Thomasville, GANPI 1639102601
Payments from drug & device makers
Across 152 payments — averaging $25.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$803
- Otsuka America Pharmaceutical, Inc.$637
- Vanda Pharmaceuticals Inc.$461
- Takeda Pharmaceuticals U.S.A., Inc.$266
- Sunovion Pharmaceuticals Inc.$264
- Bausch Health US, LLC$245
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,806100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 42 | $803 |
| Otsuka America Pharmaceutical, Inc. | 14 | $637 |
| Vanda Pharmaceuticals Inc. | 16 | $461 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $266 |
| Sunovion Pharmaceuticals Inc. | 8 | $264 |
| Bausch Health US, LLC | 10 | $245 |
| Johnson & Johnson | 2 | $140 |
| Jazz Pharmaceuticals Inc. | 7 | $131 |
| Alkermes, Inc. | 2 | $130 |
| Lundbeck LLC | 6 | $120 |
| Corium, LLC | 6 | $118 |
| Arbor Pharmaceuticals, Inc. | 5 | $77 |
| Ironshore Pharmaceuticals Inc. | 4 | $75 |
| Tris Pharma Inc | 3 | $52 |
| Novo Nordisk | 3 | $46 |
| Alfasigma USA, Inc. | 2 | $41 |
| Eisai Inc. | 2 | $39 |
| Almatica Pharma LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Rhodes Pharmaceuticals L.p. | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,806 in reported general payments places this provider in the 80th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Asenapine Maleate | 11 | $2,998 |
| Paliperidone ErPaliperidone | 13 | $1,188 |
| Olanzapine | 26 | $251 |
| Trazodone Hcl | 16 | $106 |
| Lorazepam | 12 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $15 | $25126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 900 psychiatry providers in Georgia.
Other psychiatry in Thomasville
- Robert RiesenbergAtlanta$51.1M
- Saundra Maass-RobinsonAtlanta$11.1M
- David PurselleAtlanta$7.4M
- Maria JohnsonDecatur$5.4M
- Bethany DavisAtlanta$4.4M
- Michael BanovMarietta$4.2M
- Michael MobleySavannah$2.9M
- Richard PettyLoganville$2.9M
- Felipe SuplicyRome$2.3M
- Angelo SambunarisAlpharetta$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.